---
title: "Bridging the Gap: How Bracken Supports Biotech and Pharma Companies Using Imaging Endpoints in Clinical Trials"
description: Sponsors using imaging endpoints in clinical trials are often dependent on ICLs they lack the expertise to oversee. Bracken's imaging experts bridge that gap — protecting data integrity, timelines, and submissions.
---

[Case Studies — The Bracken Group ](https://www.thebrackengroup.com/case-studies)

# [Bridging the Gap: How Bracken Supports Biotech and Pharma Companies Using Imaging Endpoints in Clinical Trials](https://www.thebrackengroup.com/case-studies/supporting-biotech-pharma-companies-using-imaging-endpoints-clinical-trials)

 Written by [Colin G. Miller](https://www.thebrackengroup.com/case-studies/author/coling-miller) | Oct 28, 2022 2:15:00 PM

The Scenario

As the use of imaging endpoints in clinical trials has increased steadily over the last 30 years, an imaging core lab (ICL) — or sometimes called an imaging CRO — is often involved.

Sponsors using imaging endpoints in clinical trials are often dependent on ICLs they lack the expertise to oversee. That knowledge gap creates real risk: inadequate oversight of ICLs can lead to data quality failures, protocol misalignment, and costly delays....  

Bracken's imaging experts bridge that gap: protecting data integrity, timelines, and submissions.

[View full post](https://www.thebrackengroup.com/case-studies/supporting-biotech-pharma-companies-using-imaging-endpoints-clinical-trials)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Colin G. Miller"
  },
  "dateModified" : "2026-06-03T00:10:46.342Z",
  "datePublished" : "2022-10-28T14:15:00Z",
  "headline" : "Bridging the Gap: How Bracken Supports Biotech and Pharma Companies Using Imaging Endpoints in Clinical Trials",
  "image" : {
    "@type" : "ImageObject",
    "height" : 2667,
    "url" : "https://4628766.fs1.hubspotusercontent-na1.net/hubfs/4628766/chub_backup/shutterstock_1693877077.jpg",
    "width" : 4000
  },
  "mainEntityOfPage" : "https://www.thebrackengroup.com/case-studies/supporting-biotech-pharma-companies-using-imaging-endpoints-clinical-trials",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "Case Studies"
  }
}
```